Marex Group (MRX) files Form 6-K with interim 2025 results and H1 statements

Rhea-AI Filing Summary

Marex Group plc submitted a Form 6-K to provide investors with its interim 2025 financial information. The company furnished a press release titled “Marex Group plc Interim 2025 Results,” issued on 13 August 2025, along with Condensed Consolidated Financial Statements for Marex Group for the six months ended June 30, 2025. These materials are included as Exhibits 99.1 and 99.2, giving readers access to the company’s mid‑year performance details and supporting financial statements.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-42020

MAREX GROUP PLC

(Translation of registrant’s name into English)

155 Bishopsgate

London EC2M 3TQ

United Kingdom

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

Earnings Results

On 13 August 2025, Marex Group plc (the “Company”) issued a press release titled “Marex Group plc Interim 2025 Results” and the Condensed Consolidated Financial Statements for Marex Group for the six months ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 herewith and a copy of the Condensed Consolidated Financial Statements is furnished as Exhibit 99.2 herewith.

EXHIBIT INDEX

The following exhibits are furnished as part of this Form 6-K:

Exhibit No.

Description

99.1

Press release dated 13 August 2025 titled “Marex Group plc Interim 2025 Results”

99.2

Condensed Consolidated Financial Statements for Marex Group for the six months ended June 30, 2025

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Marex Group plc

Date: 13 August 2024

By:

/s/ Robert Irvin

Robert Irvin

Chief Financial Officer

FAQ

What did Marex Group plc (MRX) file in this Form 6-K?

Marex Group plc filed a Form 6-K that furnishes a press release titled “Marex Group plc Interim 2025 Results” and the Condensed Consolidated Financial Statements for the six months ended June 30, 2025.

What financial period is covered by Marex Group plc’s interim 2025 results?

The interim 2025 materials cover the six months ended June 30, 2025, as indicated in the Condensed Consolidated Financial Statements furnished as Exhibit 99.2.

Which exhibits are attached to Marex Group plc’s August 2025 Form 6-K?

The filing includes Exhibit 99.1, a press release dated 13 August 2025 titled “Marex Group plc Interim 2025 Results,” and Exhibit 99.2, the Condensed Consolidated Financial Statements for the six months ended June 30, 2025.

Does this Marex Group plc (MRX) Form 6-K include full financial statements?

Yes. The Form 6-K furnishes Condensed Consolidated Financial Statements for Marex Group for the six months ended June 30, 2025 as Exhibit 99.2.

Who signed the Marex Group plc Form 6-K related to interim 2025 results?

The Form 6-K was signed on behalf of Marex Group plc by Robert Irvin, Chief Financial Officer.

What is the purpose of this Marex Group plc (MRX) interim 2025 Form 6-K?

The purpose is to furnish interim 2025 earnings information, including a results press release and condensed consolidated financial statements, to keep investors informed between annual and semi‑annual reports.